Muller, William J

14 records totalling $12,657,655.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

Muller, William J $3,769,080.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada

Oncogene-mediated signal transduction in transgenic mouse models of human breast cancer

Muller, William J $1,400,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2016-2017
Canada

Canada Research Chair Tier 1

Muller, William J $1,277,550.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2023-2024
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

MULLER, William J $1,250,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2013-2014
Canada

Role of epigenetic modulation in breast cancer etiology and drug resistance

Muller, William J $1,147,500.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2023-2024
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Muller, William J $1,139,850.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2024-2025
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2014-2015
Canada

Identification of PI-3K coupled signalling pathways involved in mammary tumour progression: Implication for resistance to targeted therapy.

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2013-2014
Canada

Oncogene-mediated signal transduction in ErbB2 transgenic models of mammary tumour progression

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2017-2018
Canada

Role of epigenetic modulation in breast cancer etiology and drug resistance.

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada

Integrin-mediated signal transduction in mammary tumourigenesis and metastasis

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2022-2023
Canada

• The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis,...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2023-2024
Canada

• The Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effec...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2025-2026
Canada

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, ef...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2023-2024
Canada

CRS/CIHR-ICR Operating Grants are intended to support Canadian researchers in their pursuit to advance scientific knowledge in the following two (2) areas: Breast Cancer, Survivorship, and supporting...